We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Outlines Clinical Data Needed To Support ‘Expedited Access’ PMAs
FDA Outlines Clinical Data Needed To Support ‘Expedited Access’ PMAs
The FDA is proposing a voluntary program to speed the approval of medical technologies that address unmet needs for life-threatening and irreversibly debilitating diseases.